These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22628917)

  • 21. Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 SDG Collaborators
    Lancet; 2018 Nov; 392(10159):2091-2138. PubMed ID: 30496107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention--a cost-effective way to fight the non-communicable disease epidemic: an academic perspective of the United Nations High-level NCD Meeting.
    Probst-Hensch N; Tanner M; Kessler C; Burri C; Künzli N
    Swiss Med Wkly; 2011; 141():w13266. PubMed ID: 21901650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tackling socioeconomic inequalities and non-communicable diseases in low-income and middle-income countries under the Sustainable Development agenda.
    Niessen LW; Mohan D; Akuoku JK; Mirelman AJ; Ahmed S; Koehlmoos TP; Trujillo A; Khan J; Peters DH
    Lancet; 2018 May; 391(10134):2036-2046. PubMed ID: 29627160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Noncommunicable diseases risk factor surveillance: experience and challenge from India.
    Deepa M; Pradeepa R; Anjana R; Mohan V
    Indian J Community Med; 2011 Dec; 36(Suppl 1):S50-6. PubMed ID: 22628912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Life-Cycle Approach for Prevention of Non Communicable Disease.
    Kelishadi R
    Adv Exp Med Biol; 2019; 1121():1-6. PubMed ID: 31392647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study (ICMR-INDIAB-17).
    Anjana RM; Unnikrishnan R; Deepa M; Pradeepa R; Tandon N; Das AK; Joshi S; Bajaj S; Jabbar PK; Das HK; Kumar A; Dhandhania VK; Bhansali A; Rao PV; Desai A; Kalra S; Gupta A; Lakshmy R; Madhu SV; Elangovan N; Chowdhury S; Venkatesan U; Subashini R; Kaur T; Dhaliwal RS; Mohan V;
    Lancet Diabetes Endocrinol; 2023 Jul; 11(7):474-489. PubMed ID: 37301218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends in premature avertable mortality from non-communicable diseases for 195 countries and territories, 1990-2017: a population-based study.
    Martinez R; Lloyd-Sherlock P; Soliz P; Ebrahim S; Vega E; Ordunez P; McKee M
    Lancet Glob Health; 2020 Apr; 8(4):e511-e523. PubMed ID: 32199120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Financial risk protection against noncommunicable diseases: trends and patterns in Bangladesh.
    Rahman T; Gasbarro D; Alam K
    BMC Public Health; 2022 Sep; 22(1):1835. PubMed ID: 36175951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Healthy people and healthy profits? Elaborating a conceptual framework for governing the commercial determinants of non-communicable diseases and identifying options for reducing risk exposure.
    Buse K; Tanaka S; Hawkes S
    Global Health; 2017 Jun; 13(1):34. PubMed ID: 28619031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of poverty reduction and development interventions on non-communicable diseases and their behavioural risk factors in low and lower-middle income countries: A systematic review.
    Pullar J; Allen L; Townsend N; Williams J; Foster C; Roberts N; Rayner M; Mikkelsen B; Branca F; Wickramasinghe K
    PLoS One; 2018; 13(2):e0193378. PubMed ID: 29474454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What are the Evidence Based Public Health Interventions for Prevention and Control of NCDs in Relation to India?
    Singh K; Reddy KS; Prabhakaran D
    Indian J Community Med; 2011 Dec; 36(Suppl 1):S23-31. PubMed ID: 22628907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The current situation and agendas in the prevention and control of non-communicable diseases in Vietnam].
    Hattori K; Uda H; Hitomi Y; Yano R; Saijo T; Watanabe N; Satomi M; Yoshida A; Oishi O; Yamashita T; Kamenosono A
    Nihon Koshu Eisei Zasshi; 2018; 65(4):170-178. PubMed ID: 29731483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Health Promotion Policies for All in Taiwan].
    Wang YW
    Hu Li Za Zhi; 2018 Oct; 65(5):5-12. PubMed ID: 30276767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Burden of non-communicable diseases from infectious causes in 2017: a modelling study.
    Coates MM; Kintu A; Gupta N; Wroe EB; Adler AJ; Kwan GF; Park PH; Rajbhandari R; Byrne AL; Casey DC; Bukhman G
    Lancet Glob Health; 2020 Dec; 8(12):e1489-e1498. PubMed ID: 33098769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incorporating a structural approach to reducing the burden of non-communicable diseases.
    Yang JS; Mamudu HM; John R
    Global Health; 2018 Jul; 14(1):66. PubMed ID: 29980215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surveillance of Noncommunicable Disease Epidemic Through the Integrated Noncommunicable Disease Collaborative Management System: Feasibility Pilot Study Conducted in the City of Ningbo, China.
    Li S; Zhang L; Liu S; Hubbard R; Li H
    J Med Internet Res; 2020 Jul; 22(7):e17340. PubMed ID: 32706706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Responding to non-communicable diseases in Zambia: a policy analysis.
    Mukanu MM; Zulu JM; Mweemba C; Mutale W
    Health Res Policy Syst; 2017 Apr; 15(1):34. PubMed ID: 28438177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Noncommunicable diseases in the Americas: a review of the Pan American Health Organization's 25-year program of work.
    Luciani S; Nederveen L; Martinez R; Caixeta R; Chavez C; Sandoval RC; Severini L; Cerón D; Gomes AB; Malik S; Gomez F; Ordunez P; Maza M; Monteiro M; Hennis A
    Rev Panam Salud Publica; 2023; 47():e13. PubMed ID: 37114168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accelerating policy response to curb non-communicable diseases: an imperative to mitigate the dual public health crises of non-communicable diseases and COVID-19 in India.
    Shrivastav R; Rawal T; Kataria I; Mehrotra R; Bassi S; Arora M
    Lancet Reg Health Southeast Asia; 2023 Mar; 10():100132. PubMed ID: 36570060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk, lifestyle and non-communicable diseases of poverty.
    Manderson L; Jewett S
    Global Health; 2023 Mar; 19(1):13. PubMed ID: 36864476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.